Dr. Noa D Sheikin

M.D. | Neurology


  240 Willoughby St, Suite 4c, Brooklyn
     New York, 11201-5465
  718-250-6940    718-250-8904 Maps & Directions
Dr. Noa D Sheikin is a Brooklyn, New York based neurologist who is specialized in Neurology. Her current practice location is 240 Willoughby St, Suite 4c, Brooklyn. Patients can reach her at 718-250-6940 or can fax her at 718-250-8904. Dr. Noa D Sheikin is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1467687574.
Dr. Noa D Sheikin specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Noa D Sheikin speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Noa D Sheikin
Specialization: Neurology
Gender:Female
Credentials: M.D.
Practice Address:240 Willoughby St, Suite 4c, Brooklyn,
New York, 11201-5465
Phone:718-250-6940
Fax:718-250-8904
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1467687574
NPI Enumeration Date: 18 May, 2009
NPI Last Update On: 01 Sep, 2016

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Noa D Sheikin
240 Willoughby St, Suite 4c
Brooklyn, New York
Zip: 11201-5465
Phone Number: 718-250-6940
Fax Number: 718-250-6940
Patients can reach Dr. Noa D Sheikin at 240 Willoughby St, Suite 4c, Brooklyn, New York or can call to book an appointment on 718-250-6940.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.